This inventor holds 1 USPTO granted patent. Top assignee: Incyte Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Sung Yong Won in Pharmaceutical Research
Introduction
Sung Yong Won is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His work focuses on innovative combinations of therapies that aim to improve patient outcomes.
Latest Patents
Sung Yong Won holds a patent for "Pharmaceutical Combinations for Treating Tumor Comprising Anti-CD19 Antibody and Natural Killer Cell." This patent represents a crucial advancement in the treatment of tumors, showcasing his commitment to developing effective therapeutic strategies.
Career Highlights
Sung Yong Won is currently employed at Incyte Corporation, a leading biopharmaceutical company. His role involves research and development in the area of oncology, where he applies his expertise to create novel treatment options for patients.
Collaborations
He collaborates with talented colleagues, including Jung Hyun Her and Mi Young Jung, to further enhance the research and development efforts at Incyte Corporation.
Conclusion
Sung Yong Won's innovative work in pharmaceutical research exemplifies the impact of dedicated inventors in the fight against cancer. His contributions continue to pave the way for new treatment possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile